Detalhe da pesquisa
1.
Mucinous ovarian carcinoma: A survey of practice in Australia and New Zealand.
Aust N Z J Obstet Gynaecol
; 2024 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38299485
2.
Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial.
Lancet Oncol
; 24(5): 468-482, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37080223
3.
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry.
Br J Cancer
; 128(7): 1360-1368, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36690721
4.
p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial.
Mod Pathol
; 35(10): 1475-1483, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35752743
5.
Why quality assurance is necessary in gynecologic radiation oncology.
Int J Gynecol Cancer
; 32(3): 402-406, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35256429
6.
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial.
Lancet Oncol
; 20(9): 1273-1285, 2019 09.
Artigo
Inglês
| MEDLINE | ID: mdl-31345626
7.
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.
Lancet Oncol
; 19(3): 295-309, 2018 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29449189
8.
Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial.
Lancet Oncol
; 17(8): 1114-1126, 2016 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-27397040
9.
Patients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: an ANZGOG substudy of the PORTEC-3 intergroup randomised trial.
Br J Cancer
; 115(10): 1179-1185, 2016 Nov 08.
Artigo
Inglês
| MEDLINE | ID: mdl-27764842
10.
Smokers with cervix cancer have more uterine corpus invasive disease and an increased risk of recurrence after treatment with chemoradiation.
Int J Gynecol Cancer
; 24(7): 1286-91, 2014 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-24987916
11.
Prognostic significance of lymphovascular space invasion and nodal involvement in intermediate- and high-risk endometrial cancer patients treated with curative intent using surgery and adjuvant radiotherapy.
Int J Gynecol Cancer
; 22(2): 260-6, 2012 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-22080878
12.
ENhAncing Lifestyle Behaviors in EndometriaL CancEr (ENABLE): A Pilot Randomized Controlled Trial.
Integr Cancer Ther
; 21: 15347354211069885, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35045735
13.
Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation Therapy.
Int J Radiat Oncol Biol Phys
; 112(2): 390-399, 2022 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34610387
14.
Long-Term Toxicity and Health-Related Quality of Life After Adjuvant Chemoradiation Therapy or Radiation Therapy Alone for High-Risk Endometrial Cancer in the Randomized PORTEC-3 Trial.
Int J Radiat Oncol Biol Phys
; 109(4): 975-986, 2021 03 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33129910
15.
Patterns of practice survey for brachytherapy for cervix cancer in Australia and New Zealand.
J Med Imaging Radiat Oncol
; 61(5): 674-681, 2017 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-28470944
16.
Stage IB cervix cancer with nodal involvement treated with primary surgery or primary radiotherapy: Patterns of failure and outcomes in a contemporary population.
J Med Imaging Radiat Oncol
; 60(2): 274-82, 2016 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-26549207
17.
Carcinoma of the cervix in elderly patients treated with radiotherapy: patterns of care and treatment outcomes.
J Gynecol Oncol
; 27(6): e59, 2016 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-27550405
18.
Clinical outcomes from an innovative protocol using serial ultrasound imaging and a single MR image to guide brachytherapy for locally advanced cervix cancer.
Brachytherapy
; 15(6): 817-824, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27593599
19.
Results of the Australasian (Trans-Tasman Oncology Group) radiotherapy benchmarking exercise in preparation for participation in the PORTEC-3 trial.
J Med Imaging Radiat Oncol
; 60(4): 554-9, 2016 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-27059658
20.
Ultrasound guided conformal brachytherapy of cervix cancer: survival, patterns of failure, and late complications.
J Gynecol Oncol
; 25(3): 206-13, 2014 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-25045433